VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO WCGIC 2020 | GASTHER2: trastuzumab for advanced gastric cancer

Rachel Riechelmann, MD, PhD, AC Camargo Cancer Canter, São Paulo, Brazil, outlines the rationale behind the GASTHER2 (NCT04168931) study evaluating trastuzumab for patients with advanced gastric cancer with HER2 positive expression in circulating tumour cells. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter